09:10 AM EDT, 05/08/2024 (MT Newswires) -- Vericel ( VCEL ) reported a Q1 loss Wednesday of $0.08 per diluted share, narrowing from a loss of $0.16 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.11.

Revenue for the quarter ended March 31 was $51.3 million, up from $41 million a year earlier.

Analysts surveyed by Capital IQ expected $49.1 million.

For 2024, the sports medicine and burn treatment products provider raised its revenue guidance to $238 million to $242 million, up from $237 million to $241 million. Analysts surveyed by Capital IQ expect $239.2 million.

Vericel ( VCEL ) shares were up 3% in recent Wednesday premarket activity.

Price: 51.00, Change: +1.48, Percent Change: +2.99